HemaQuest Pharmaceuticals Receives $4,000,000 Series B Round

  • Feed Type
  • Date
  • Company Name
    HemaQuest Pharmaceuticals
  • Mailing Address
    1229 Madison Street Seattle, WA 98104
  • Company Description
    HemaQuest is a company developing proprietary small molecule therapeutics to treat serious blood disorders.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    The financing will be used to help push HemaQuest’s two lead drug candidates through mid-stage clinical trials designed to show they are safe and effective.
  • M&A Terms
  • Venture Investor
    Latterell Venture Partners

Trending on Xconomy